Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2018-08-28
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cigar Flavor in Dual Users
NCT04487470
Little Cigar and Cigarillo Warnings for Youth
NCT06413797
Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs
NCT05849051
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease - Eye Tracking
NCT06546618
Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults
NCT02937051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavored LCCs
Half of the group will start with a flavored little cigar/cigarillo (LCC) and cross over to unflavored LCC. The LCCs will be a popular brand already available for sale on the market.
Flavored and unflavored little cigars/cigarillos (LCCs)
Flavored and unflavored LCCs that are currently available for purchase
Unflavored LCCs
Half of the group will start with an unflavored little cigar/cigarillo (LCC) and cross over to flavored LCC. The LCCs will be a popular brand already available for sale on the market.
Flavored and unflavored little cigars/cigarillos (LCCs)
Flavored and unflavored LCCs that are currently available for purchase
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavored and unflavored little cigars/cigarillos (LCCs)
Flavored and unflavored LCCs that are currently available for purchase
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak, read and understand English
* Age 18-34 years of age
* Stable residence (not planning to move during study period)
* Not intending to quit smoking cigarettes or LCCs within the next 2 weeks
* An expired carbon monoxide (CO) level of at least 4 ppm of expired air to verify smoking status
Exclusion Criteria
* Current use of (or plans to use in the next 2-3 weeks) nicotine replacement products or cessation products (e.g., bupropion) to minimize confounding effects of another product)
* Positive breath alcohol screen (breath alcohol level (BAL) \> 0 g/ml; one re-test allowed; assessed at Visits 1, 2, and 3)
* Illicit drug use other than marijuana (verified by positive drug toxicology test at Visits 1 and 3; one re-test allowed)
* Met criteria for Cannabis Dependence assessed by the Cannabis Use Disorders Identification Test-Revised (CUDIT-R)
18 Years
34 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UConn Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erin Mead-Morse
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin L Mead, PhD,MHS
Role: PRINCIPAL_INVESTIGATOR
UConn Health, Farmington, CT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UConn Health
Farmington, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-091-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.